Aeromonas jandaei

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Aeromonas jandaei is a Gram-negative, non-spore-forming, aerobic, motile, rod-shaped bacterium. It has been detected in at least 2 gut microbiome compilation studies or metastudies. The DNA G+C content is 58.1-61.1%. Aeromonas jandaei is probably a rare gut coloniser. (Esteve2003; Igbinosa2012; MartinCarnahan2005Bergey)



  • This organism has been recovered from human faeces (CCUG), clinical specimens (wound -CCUG) and the environment. The risk classification (www.baua.de) for this organism is 2, i.e., risk of individual infection, but low risk of spread (notes: human and animal pathogen). It is an opportunistic pathogen. A possible gut commensal.
    • GENERAL CHARACTERISTICS (Esteve2003); (Igbinosa2012); (MartinCarnahan2005Bergey);
    Character Response
  • Substrates hydrolysed or digested:
  • casein; gelatin;
  • 🧂
  • Salt tolerance:
  • tolerates 0% salt; tolerates 3% salt;
  • pH
  • Acidity tolerance:
  • doesn't tolerate pH 4.5; tolerates pH 8.5;
  • 🌡
  • Temperature tolerance:
  • grows at 4℃; grows at 42℃;
  • H+
  • Acid from carbohydrates usually produced:
  • fructose; galactose; glucose; mannose; ribose; maltose; trehalose; glycerol; mannitol;
  • ⥅
  • Substrates assimilated or utilised:
  • N-acetylglucosamine; gluconate; glucose; melibiose; cysteine; glutamate; proline; serine; acetate; citrate; fumarate; malate; succinate; glutamine;
  • ±
  • Strain-dependent substrate utilisation:
  • histidine;
  • Active enzymes:
  • arginine dihydrolase; α-galactosidase; β-galactosidase; lycine decarboxylase; oxidase;
    • SPECIAL FEATURES (Esteve2003); (Igbinosa2012); (MartinCarnahan2005Bergey);
    Character Response
  • ✓
  • Metabolites produced:
  • H₂S; indole;
  • ✓
  • VP test:
  • active
  • ✓
  • NO3➔NO2:
  • reduced
  • ✗
  • Pigments:
  • not produced
    • RESPONSE TO ANTIBIOTICS (Esteve2003); (Igbinosa2012); (MartinCarnahan2005Bergey);
    Class Active Resistant
  • Penicillins:
  • aztreonam; imipenem;
  • ampicillin; carbenicillin; penicillin; piperacillin;
  • Cephalosporins:
  • cefepime; cefixime; cefotaxime; cefoxitin; ceftazidime; cephalothin;
  • Macrolides:
  • erythromycin;
  • Tetracyclines:
  • tetracycline;
  • Quinolines:
  • nalidixic-acid; ofloxacin;
  • Aminoglycosides:
  • amikacin; gentamicin; kanamycin; streptomycin; tobramycin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • chloramphenicol; co-trimoxazole; nitrofurantoin;
  • sulfadimethoxine; sulfanilamide; trimethoprim;
  • Miscellaneous antibiotics:
  • polymyxin B;
  • colistin;

  • Aeromonas jandaei and Aeromonas veronii rarely can cause infection of human wounds following aquatic exposure.

  • Janda, J. M., & Abbott, S. L. (1998). Evolving concepts regarding the genus Aeromonas: an expanding Panorama of species, disease presentations, and unanswered questions. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 27(2), 332–344.

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Proteobacteria Class:  Gammaproteobacteria Order:  Aeromonadales Family:  Aeromonadaceae Genus:  Aeromonas Gram stain:  neg O2 Relation.:  aerobic Spore:  No spore Motility:  Swimming Morphology:  Rod Pigment:  neg
    Health:  Unknown
    Source:  human faeces (CCUG), clinical specimens (wound -CCUG) and the environment
    DNA G+C(%):  58.1-61.1
    Low T(℃):  4(+)
    High T(℃):  42(+)
    NaCl 0.5-2%:  0(+)
    NaCl 3-5%:  3(+)
    pH 4.2-5.9:  4.5(neg)
    pH 6.0-8.0:  8.5(+)
    		Aesculin:  neg Urea:  neg Gelatin:  + Casein:  + Alginate:  neg Tween:  80(d)
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  neg D-Arabinose:  neg L-Arabinose:  neg Fructose:  + Galactose:  + Glucose:  + Mannose:  + Rhamnose:  neg Ribose:  + Xylose:  neg Cellubiose:  neg Maltose:  + Melibiose:  neg Sucrose:  neg Trehalose:  + Amygdalin:  neg Adonitol:  neg D-Arabitol:  neg L-Arabitol:  neg Dulcitol:  neg Glycerol:  + Inositol:  neg Mannitol:  + Sorbitol:  neg Xylitol:  neg Arbutin:  neg 5-Ketogluconate:  neg Salicin:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    L-Arabinose:  neg Glucose:  + Melibiose:  + N_Acetyl_glucosamine:  + Gluconate:  + Ala:  neg 4-Aminobutyrate:  neg Arg:  neg Asp:  neg L-Citrulline:  neg Cys:  + Glu:  + Gly:  neg His:  d Ile:  neg Leu:  neg Lys:  neg Met:  neg Orn:  neg Phe:  neg Pro:  + Sarcosine:  neg Ser:  + Thr:  neg Trp:  neg Tyr:  neg Val:  neg Acetate:  + Aconitate:  neg Benzoate:  neg Citrate:  + Fumarate:  + Glutarate:  neg DL-Glycerate:  neg Lactate:  neg Malate:  + Maleate:  neg Malonate:  neg Mucate:  neg Propionate:  neg Succinate:  + L-Tartrate:  neg
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  + Urease:  neg Ac-β-glcamnd:  neg α-Galactosidase:  + β-Galactosidase:  + α-Glucosidase:  neg β-Glucosidase:  neg β-Glucuronidase:  neg ArgDH:  + GluDC:  neg LysDC:  + OrnDC:  neg Lipase:  vr
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		H2S:  + Indole:  + Pigment:  neg
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    ampicillin:  R(50; disc)
    aztreonam:  Sens
    carbenicil:  R(30; disc)
    penicillin:  R(10; disc)
    piperacillin:  Res
    imipenem:  Sens
    cefazolin:  Var
    cefepime:  Sens
    cefixime:  Sens
    cefotaxime:  Sens
    cefoxitin:  Sens
    ceftazidime:  Sens
    cephalothin:  S(30; disc)
    amikacin:  S(25; disc)
    gentamicin:  S(10; disc)
    kanamycin:  S(50; disc)
    streptomycin:  S(25; disc)
    tobramycin:  S(25; disc)
    erythromycin:  S(15; disc)
    nalidixic-acid:  S(50; disc)
    ofloxacin:  Sens
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  Sens
    rifampicin:  S(30; disc)
    chloramphenicol:  S(25; disc)
    nitrofurantoin:  S(10; disc)
    sulfadimethoxine:  R(12; disc)
    sulfanilamide:  R(300; disc)
    trimethoprim:  R(25; disc)
    co-trimoxazole:  Sens
    colistin:  R(4; disc)
    polymyxin_B:  S(300U)

    References

    SPECIFIC REFERENCES FOR AEROMONAS JANDAEI
  • Esteve2003 - Taxonomic study of sucrose-positive Aeromonas jandaei-like isolates from faeces, water and eels: emendation of A. jandaei Carnahan et al. 1992.
  • Igbinosa2012 - Emerging Aeromonas Species Infections and Their Significance in Public Health.
  • MartinCarnahan2005Bergey - Bergey's manual of systematic bacteriology. Vol. 2, The Gammaproteobacteria Part B. Family Aeromonadaceae, Genus I. Aeromonas
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR AEROMONAS JANDAEI
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • ...............................
    • GENERAL REFERENCES FOR AEROMONAS JANDAEI
  • CCUG - Culture Collection University of Gothenburg - Entire Collection
  • Igbinosa2012 - Emerging Aeromonas Species Infections and Their Significance in Public Health.
    • Added: April 08, 2021